Evidence map›Paper›PMID 41767122›Full record

ArticleJIMD reports2026

Clinical Outcomes and Management in Late Diagnosed Siblings Affected With Attenuated GSD Ib.

Gregory Lynch, Alison Woodall, Charlotte Dawson, Philip Newsome, Maria Veiga-da-Cunha, Karolina M Stepien

Abstract read
In one paragraph

Article in JIMD reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gregory LynchClinical Biochemistry Department Northern Care Alliance NHS Foundation Trust Salford UK.
Alison WoodallAdult Inherited Metabolic Diseases Northern Care Alliance NHS Foundation Trust Salford UK.
Charlotte DawsonAdult Inherited Metabolic Disorders University Hospitals Birmingham NHS Foundation Trust Birmingham UK.
Philip NewsomeFaculty of Life Sciences and Medicine, King's College London, Foundation for Liver Research & King's College Hospital Roger Williams Institute of Liver Studies London UK.
Maria Veiga-da-CunhaGroupe de Recherches Metaboliques, de Duve Institute UCLouvain Brussels Belgium.ORCID https://orcid.org/0000-0002-2968-7374
Karolina M StepienAdult Inherited Metabolic Diseases Northern Care Alliance NHS Foundation Trust Salford UK.ORCID https://orcid.org/0000-0003-0148-6332

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glycogen storage disease 1b (GSD1b) typically presents in early infancy with poor fasting tolerance, hepatomegaly, and neutropenia. We report two siblings who were diagnosed with GSD1b in adulthood. Both had a normal fasting tolerance throughout childhood and, as adults, were able to fast for at least 16 h without developing hypoglycaemia. The older sibling developed nodular cirrhosis during adolescence. The younger sibling exhibited a more pronounced metabolic phenotype, including hyperuricaemia leading to recurrent gout and nephrolithiasis. He experienced occasional episodes of mild neutropenia that were corrected with empagliflozin treatment. To our knowledge, these represent the first reported patients with GSD1b presenting in adulthood with non-hypoglycaemic complications of the disease and without overt neutropenia or neutrophil dysfunction.

Indexed as

attenuatedempagliflozinglycogen storage disease Iblong‐term outcomenatural history

Identifiers

PMID41767122
PMCPMC12946512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.